Literature DB >> 12064907

Congenital transcobalamin II deficiency due to errors in RNA editing.

Lian Qian1, Edward V Quadros, Annette Regec, Jacqueline Zittoun, Sheldon P Rothenberg.   

Abstract

Transcobalamin II (TCII) is a plasma protein essential for the transport and cellular uptake of vitamin B12 (B12; cobalamin, Cbl). Congenital deficiency of functional TCII is an autosomal recessive genetic disorder that results in clinical B12 deficiency usually within several months following birth. In this report, we describe the molecular basis for TCII deficiency in two patients who developed a megaloblastic anemia in early infancy. The serum of both patients contained immunoreactive TCII that did not bind [57Co]Cbl. The fibroblasts from each patient secreted a similarly nonfunctional TCII, yet full-length TCII transcripts were identified by Northern blot. Overlapping cDNA fragments were generated by reverse transcription-polymerase chain reaction and several mutations were identified in the coding region of the cDNA, one of which was common to both patients. However, amplification of the corresponding regions of the gene from genomic DNA failed to identify these mutations. These findings were confirmed by replicate analyses and support the proposal that a variance in RNA editing is the likely mechanism for the mutations that resulted in the expression of a nonfunctional TCII protein in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064907     DOI: 10.1006/bcmd.2002.0499

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  9 in total

1.  Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents.

Authors:  Peter H Nissen; Maria Nordwall; Elke Hoffmann-Lücke; Boe S Sorensen; Ebba Nexo
Journal:  J Inherit Metab Dis       Date:  2010-07-06       Impact factor: 4.982

2.  Should transcobalamin deficiency be treated aggressively?

Authors:  Manuel Schiff; Hélène Ogier de Baulny; Ghislaine Bard; Vincent Barlogis; Christian Hamel; Stuart J Moat; Sylvie Odent; Graham Shortland; Guy Touati; Stéphane Giraudier
Journal:  J Inherit Metab Dis       Date:  2010-03-30       Impact factor: 4.982

3.  A novel mutation of the transcobalamin II gene in an infant presenting with hemophagocytic lymphohistiocytosis.

Authors:  Selma Unal; Ozlem Tezol; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-02-22       Impact factor: 2.490

Review 4.  Cellular uptake of cobalamin: transcobalamin and the TCblR/CD320 receptor.

Authors:  Edward V Quadros; Jeffrey M Sequeira
Journal:  Biochimie       Date:  2013-02-14       Impact factor: 4.079

Review 5.  Vitamin B12 transport from food to the body's cells--a sophisticated, multistep pathway.

Authors:  Marianne J Nielsen; Mie R Rasmussen; Christian B F Andersen; Ebba Nexø; Søren K Moestrup
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-01       Impact factor: 46.802

Review 6.  Advances in the understanding of cobalamin assimilation and metabolism.

Authors:  Edward V Quadros
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

7.  The association between vitamin B12, albuminuria and reduced kidney function: an observational cohort study.

Authors:  Gearoid M McMahon; Shih-Jen Hwang; Rikki M Tanner; Paul F Jacques; Jacob Selhub; Paul Muntner; Caroline S Fox
Journal:  BMC Nephrol       Date:  2015-02-02       Impact factor: 2.388

8.  Clinical, phenotypic and genetic landscape of case reports with genetically proven inherited disorders of vitamin B12 metabolism: A meta-analysis.

Authors:  Arnaud Wiedemann; Abderrahim Oussalah; Nathalie Lamireau; Maurane Théron; Melissa Julien; Jean-Philippe Mergnac; Baptiste Augay; Pauline Deniaud; Tom Alix; Marine Frayssinoux; François Feillet; Jean-Louis Guéant
Journal:  Cell Rep Med       Date:  2022-06-27

9.  Identification of transcobalamin deficiency with two novel mutations in the TCN2 gene in a Chinese girl with abnormal immunity: a case report.

Authors:  Shihong Zhan; Fangfang Cheng; Hailong He; Shaoyan Hu; Xing Feng
Journal:  BMC Pediatr       Date:  2020-10-06       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.